We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGR
9226
CALL
DELISTED
Vector Group Ltd.
VGR
-18,429
Closed -$242K
VGR
9227
DELISTED
Vector Group Ltd.
VGR
-37,898
Closed -$478K
EVA
9228
DELISTED
Enviva Inc.
EVA
-7,844
Closed -$215K
GTHX
9229
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-8,324
Closed -$308K
ALIM
9230
DELISTED
Alimera Sciences
ALIM
-2,709
Closed -$42K
CTR
9231
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
-2,721
Closed -$134K
BIMI
9232
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
-324
Closed -$23K
AIU
9233
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
-290
Closed -$390K
WPS
9234
DELISTED
iShares International Developed Property ETF
WPS
-80,201
Closed -$3.13M
MODN
9235
PUT
DELISTED
MODEL N, INC.
MODN
-17,200
Closed -$310K
TARO
9236
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-5,968
Closed -$589K
GENE
9237
DELISTED
Genetic Technologies Ltd.
GENE
-893
Closed -$19K
TRVN
9238
DELISTED
Trevena, Inc.
TRVN
-24
Closed -$26.4K
YTEN
9239
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
-17
Closed -$32K
SCTL
9240
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-12,731
Closed -$126K
MTBL
9241
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-570,667
Closed -$1.44M
MTBL
9242
PUT
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-146,333
Closed -$369K
VJET
9243
CALL
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
-4,000
Closed -$69K
NEPT
9244
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-27
Closed -$109K
LBC
9245
DELISTED
Luther Burbank Corporation Common Stock
LBC
-37,837
Closed -$455K
SIEN
9246
DELISTED
Sientra, Inc.
SIEN
-2,225
Closed -$353K
PGAL
9247
DELISTED
Global X MSCI Portugal ETF
PGAL
-38,166
Closed -$468K
DMK
9248
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-511
Closed -$125K
RESP
9249
DELISTED
WisdomTree U.S. ESG Fund
RESP
-21,895
Closed -$682K
SRC
9250
CALL
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-2,364
Closed -$82K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.